Opioid Use Disorder Market
Report ID: SQMIG35D2365
Report ID: SQMIG35D2365
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35D2365 |
Region:
Global |
Published Date: January, 2026
Pages:
175
|Tables:
91
|Figures:
66
Global Opioid Use Disorder Market size was valued at USD 5.7 Billion in 2024 and is poised to grow from USD 6.37 Billion in 2025 to USD 15.56 Billion by 2033, growing at a CAGR of 11.8% during the forecast period (2026–2033).
The surge in drug abuse incidence, government support to promote opioid use disorder (OUD) awareness, launch of awareness programs for OUD, and expansion of treatment infrastructure are helping boost the demand for opioid use disorder over the coming years.
Rapidly increasing misuse of prescription opioids, heroin, and synthetic analogues around the world is prompting the demand for opioid use disorder treatment solutions. Prioritization of opioid use disorder treatment and awareness by governments and public health agencies around the world is also creating new opportunities in the long run. Greater public, professional and stakeholder awareness of opioid addiction is also supplementing opioid use disorder market growth across the study period. The increase in the number and capacity of treatment centres, outpatient clinics, telehealth services and integrated care programs has improved access to OUD care, which also boosts revenue generation.
On the contrary, social stigma resulting in patient reluctance for treatment, limited access to care in developing regions, high costs of treatment, and regulatory hurdles are estimated to limit the global opioid use disorder market penetration through 2032 and beyond.
How Digital Health is Shaping Opioid Use Disorder Treatment?
Telemedicine and digital health solutions are increasingly integrated into OUD treatment programs, enabling remote consultations, therapy sessions, and real-time monitoring. Mobile applications provide medication reminders, behavioral therapy support, and patient engagement analytics, improving adherence and treatment outcomes. Telehealth allows rural and underserved populations to access MAT and counseling without geographic constraints, broadening market reach. Digital platforms also facilitate data collection, personalized treatment adjustments, and remote provider oversight. The convergence of technology with addiction care is transforming service delivery, creating scalable, patient-centered solutions that expand OUD treatment accessibility and efficiency globally, and enhancing market growth.
Market snapshot - 2026-2033
Global Market Size
USD 5.1 billion
Largest Segment
Oral Administration
Fastest Growth
Injectable Administration
Growth Rate
11.8% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Opioid Use Disorder Market is segmented by Treatment, Route of Administration, Distribution Channel, End-User and region. Based on Treatment, the market is segmented into Methadone, Buprenorphine, Naltrexone and Other Therapies. Based on Route of Administration, the market is segmented into Oral, Injectable / Implant and Transdermal / Other. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online / E-commerce. Based on End-User, the market is segmented into Outpatient Clinics, Inpatient / Residential Treatment Centres and Remote Care. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The consumables segment is estimated to hold the highest global opioid use disorder market share going forward. Repeated purchase of consumables such as assay kits, sample collection devices, and calibrators is helping this segment hold sway over others. High reliance on consumables for any type of drug testing and screening is also expected to further cement the high share of this segment in the future.
On the other hand, the demand for services and other goods is expected to rise at a robust pace over the coming years as per this opioid use disorder market forecast. Need specialized services for drug testing and screening coupled with adoption of innovative opioid use disorder programs are helping create new business scope.
The urine samples segment is slated to spearhead the global opioid use disorder market revenue generation potential over the coming years. Ease of collection associated with urine samples makes it a preferred sample for opioid use disorder. Easy detection of a wide range of drugs and non-invasive nature of urine sampling are also expected to help bolster the dominance of this segment over the coming years.
Meanwhile, the use of oral fluid samples for opioid use disorders is slated to rise at a notable pace in the coming. High preference for less invasive drug testing solutions and growing demand for efficient testing solutions are helping create new opportunities for market players in the long run.
To get detailed segments analysis, Request a Free Sample Report
Severe opioid epidemic and widespread adoption of medication-assisted treatments (MAT) are helping this region lead the global opioid use disorder industry. Awareness campaigns and educational programs play a crucial role in reducing stigma associated with opioid use disorders, which promotes treatment adoption. Extensive research, clinical trials, and the presence of major pharmaceutical companies developing opioid use disorder treatments are also helping cement the dominance of North America over the coming years.
The country is known globally for a severe opioid crisis that has been going on for years now. Rapidly surging number of deaths in the United States due to drug overdoses and illegal drug trade operations from Mexico are helping boost the demand for opioid use disorder treatment in the country. Despite multiple efforts to regulate drug use and curb illegal substance use, the country has failed to achieve reduction in opioid use disorders. This makes it a highly opportune yet challenging market to win over.
Rising cases of drug overdose, growing illicit use of fentanyl, and growing misuse of prescription drugs are helping boost opioid use disorder treatment demand in Canada. High rates of hospitalization due to opioid use in British Columbia, Alberta, Yukon, and the Northwest Territories of the country are also creating new opportunities for market players. The spillover of illicit drug trade in the United States is also a key factor influencing demand in Canada.
Increasing opioid abuse rates, growing awareness regarding addiction treatment, and rising cases of opioid misuse are helping this region emerge as a highly opportune one. Government initiatives and NGO-supported awareness programs are encouraging treatment-seeking behaviors.. Investment in addiction care facilities and pharmaceutical partnerships with global players accelerates adoption, positioning Asia Pacific as a dynamic and high-growth market for opioid use disorders.
Rising awareness regarding addiction issues and emphasis on integrating innovative therapies are helping drive opioid use disorder treatment demand in Japan. The country maintains strict government oversight over drug use through the Narcotics and Psychotropics Control Act, which has curbed the misuse of opioids. Emphasis on stoicism and enduring pain as a virtue has also helped the country reduce the use of opioids naturally thereby reducing the need for advanced opioid use disorder treatments.
Older adults with chronic pain conditions are estimated to play a crucial role in governing the demand for opioid use disorder treatment in the country. High misuse of prescription drugs, use of digital health tools to improve treatment adherence, and growing number of people on long term opioid use are expected to ensure sustained market growth in South Korea. Telehealth platforms are also anticipated to improve opioid use disorder treatment adherence.
Rise in awareness regarding opioid use disorder and government support for harm reduction are forecasted to influence market growth in Europe. Launch of new regulatory frameworks promoting opioid addiction treatment and integrating counseling, rehabilitation, and pharmaceutical interventions in multiple European countries is also driving revenue. Emphasis on digital health integration and adoption of outpatient treatment models is also estimated to expand the business scope for opioid use disorder companies.
Public health policies emphasizing harm reduction and integrated care are expected to govern the opioid use disorder industry growth in this country. Accessibility to MAT and rehabilitation services in the United Kingdom is facilitated by the National Health Service (NHS). Government initiatives to promote awareness regarding opioid use disorder and efforts to reduce opioid-related deaths are slated to ensure sustained market development across the study period.
Growing incidence of chronic pain, backed by a shift in demographics and rise in surgical procedure volumes, is helping drive opioid use disorder treatment demand in Germany. The preference for opioid use disorder drugs with extended-release and abuse-deterrent formulations is high in the country. Emphasis on opioid harm reduction and improving opioid use disorder treatment accessibility are also creating new opportunities in Germany.
Socioeconomic disparities and the availability of prescription opioids are playing a vital role in influencing the opioid use disorder market in France. Emphasis on integration of MAT in primary care settings and the availability of take-home naloxone kits are also expected to create new business scope for market players. Government support is critical in shaping the opioid use disorder landscape in the country through 2032.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Innovations in Pharmacotherapy and New Formulations
Expansion of Treatment Infrastructure and Service Coverage
Social Stigma and Patient Reluctance to Seek Treatment
Limited Access to Care in Underserved and Rural Areas
Request Free Customization of this report to help us to meet your business objectives.
Opioid use disorder providers should focus on enhancing the efficiency of their products and developing non-invasive testing solutions. Raising awareness regarding substance abuse can also help improve business scope for opioid use disorder providers. Investing in the R&D of novel portable and rapid tests is also a prominent opportunity for companies as per this global opioid use disorder market analysis.
Reducing the test and result times coupled with integration of advanced technologies is slated to help improve efficacy of drug testing. Here’s a startup that has the potential to augment the opioid use disorder industry in the long run.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, a growing incidence of substance abuse and a growing emphasis on preventive care are anticipated to drive the demand for opioid use disorder going forward. However, limited detection windows and ethical concerns regarding drug testing are slated to slow down the adoption of opioid use disorder in the future. North America is slated to spearhead the demand for opioid use disorder owing to high number of drug abuse cases and stringent regulatory requirements. Development of at-home drug testing kits and emphasis on non-invasive testing are anticipated to be key trends driving the opioid use disorder industry through 2032 and beyond.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 5.7 Billion |
| Market size value in 2033 | USD 15.56 Billion |
| Growth Rate | 11.8% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Opioid Use Disorder Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Opioid Use Disorder Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Opioid Use Disorder Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Opioid Use Disorder Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
